REFERENCES
1. Pavlova EL, Simeonova LS, Gegova GA. Combined efficacy of
oseltamivir, isoprinosine and ellagic acid in influenza A(H3N2)-infected
mice. Biomed Pharmacother.
2018;98:29-35.
2. Park SW, Kwon MJ, Yoo JY, Choi H-J, Ahn Y-J. Antiviral activity and
possible mode of action of ellagic acid identified in Lagerstroemia
speciosa leaves toward human rhinoviruses. BMC Complement Altern Med.
2014 May 26;14:171.
3. Cui Q, Du R, Anantpadma M, Schafer A, Hou L, Tian J, et al.
Identification of ellagic acid from plant Rhodiola rosea L. as an
anti-Ebola virus entry inhibitor. Viruses. 2018 27;10(4). pii: E152.
4. Promsong A, Chuenchitra T, Saipin K, Tewtrakul S, Panichayupakaranant
P, Satthakarn S,et al. Ellagic acid inhibits HIV-1 infection in vitro:
Potential role as a novel microbicide. Oral Dis. 2018;24(1-2):249-252.
5. Vilhelmova-Ilieva N, Jacquet R, Deffieux D, Pouységu L, Sylla T,
Chassaing S. Anti-Herpes Simplex Virus Type 1 Activity of Specially
Selected Groups of Tannins. Drug Res (Stuttg). 2019 Jul;69(7):374-373.
6. Pavlova EL, Zografov NN, Simeonova
LS. Comparative study on the antioxidant capacities of synthetic
influenza inhibitors and ellagic acid in model
systems. Biomed Pharmacother. 2016
Oct;83:755-762.
7. Aslan A, Hussein YT, Gok O, Beyaz S, Erman O, Baspinar S. Ellagic
acid ameliorates lung damage in rats via modulating antioxidant
activities, inhibitory effects on inflammatory mediators and
apoptosis-inducing activities. Environ Sci Pollut Res Int. 2020
Mar;27(7):7526-7537.
8. Cornélio Favarin D, Martins
Teixeira M, Lemos de Andrade E, de Freitas Alves C, Lazo Chica JE,
Artério Sorgi C, et al. Anti-inflammatory effects of ellagic acid on
acute lung injury induced by acid in mice. Mediators Inflamm.
2013;2013:164202.